Larimar Therapeutics, Inc. (LRMR)
NGM – Real Time Price. Currency in USD
4.13
+0.04 (0.98%)
At close: May 12, 2026, 4:00 PM EDT
4.13
0.00 (0.00%)
After-hours: May 12, 2026, 6:20 PM EDT
Find any stock by ticker or company name

NGM – Real Time Price. Currency in USD
4.13
+0.04 (0.98%)
At close: May 12, 2026, 4:00 PM EDT
4.13
0.00 (0.00%)
After-hours: May 12, 2026, 6:20 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $85.4M significantly exceed its total debt $4.1M, ensuring strong financial flexibility
Total current assets $142.0M exceed Total current liabilities $64.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$38.5M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.19 | 6.05 | 10 | |
| Quick ratio | 2.19 | 5.63 | 10 | |
| Debt to Equity | 0.05 | 0.30 | 9.0 | |
| Debt to Assets | 0.03 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -272K | -311K | -318K | -350K | -350K |
| Operating Income | -37M | -42M | -91M | -172M | -172M |
| Net Income | -35M | -37M | -81M | -166M | -166M |
| EBITDA | -36M | -41M | -91M | -172M | -172M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -15.57 | 1.0 |
| Next quarter | N/A | -11.43 | 1.0 |
| Current year | N/A | 15.08 | 5.0 |
| Next year | N/A | 22.51 | 5.5 |
| Weighted average score | 3.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -30.98 | -19.66 | -33.88 | 3.3 |
| Y/Y | 999 | -116.82 | -62.21 | -75.16 | 3.3 |
| 3y average | 999 | -76.05 | -30.12 | -64.13 | 3.3 |
| 5y average | 999 | -43.42 | -3.88 | -31.59 | 3.3 |
| Weighted average score | 3.3 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |